Adjunctive use of a subgingival controlled-release chlorhexidine chip reduces probing depth and improves attachment level compared with scaling and root planing alone.

PubWeight™: 1.37‹?› | Rank: Top 10%

🔗 View Article (PMID 9776027)

Published in J Periodontol on September 01, 1998

Authors

M K Jeffcoat1, K S Bray, S G Ciancio, A R Dentino, D H Fine, J M Gordon, J C Gunsolley, W J Killoy, R A Lowenguth, N I Magnusson, S Offenbacher, K G Palcanis, H M Proskin, R D Finkelman, M Flashner

Author Affiliations

1: Department of Periodontics, University of Alabama, Birmingham 35294-0007, USA.

Articles citing this

Controlled release of chlorhexidine from UDMA-TEGDMA resin. J Dent Res (2006) 1.08

The effects of different concentrations of chlorhexidine gluconate on the antimicrobial properties of mineral trioxide aggregate and calcium enrich mixture. Dent Res J (Isfahan) (2012) 0.86

Effectiveness of a controlled release chlorhexidine chip (PerioCol™-CG) as an adjunctive to scaling and root planing when compared to scaling and root planing alone in the treatment of chronic periodontitis: A comparative study. J Indian Soc Periodontol (2012) 0.86

Connective Tissue Reaction to White and Gray MTA Mixed With Distilled Water or Chlorhexidine in Rats. Iran Endod J (2009) 0.85

Isolation of a novel bacteriophage specific for the periodontal pathogen Fusobacterium nucleatum. Appl Environ Microbiol (2010) 0.84

Effect of insertion of xanthan-based chlorhexidine gel in the maintenance phase following the treatment of chronic periodontitis. J Indian Soc Periodontol (2012) 0.82

Effect of chlorhexidine chip in the treatment of chronic periodontitis. J Nat Sci Biol Med (2014) 0.82

To assess the effectiveness of a chlorhexidine chip in the treatment of chronic periodontitis: A clinical and radiographic study. J Indian Soc Periodontol (2011) 0.80

Chlorhexidine chip in the treatment of chronic periodontitis - a clinical study. J Clin Diagn Res (2014) 0.79

Effect of controlled-release Periochip™ on clinical and microbiological parameters in patients of chronic periodontitis. J Indian Soc Periodontol (2013) 0.78

Comparison of the efficacy of chlorhexidine varnish and chip in the treatment of chronic periodontitis. Contemp Clin Dent (2013) 0.77

Clinical and antimicrobial efficacy of a controlled-release device containing chlorhexidine in the treatment of chronic periodontitis. Eur J Clin Microbiol Infect Dis (2015) 0.77

Successful treatment of osseous lesion associated with palatoradicular groove using local drug delivery and guided tissue regeneration: A report of two cases. J Pharm Bioallied Sci (2012) 0.77

The study of release of chlorhexidine from preparations with modified thermosensitive poly-N-isopropylacrylamide microspheres. ScientificWorldJournal (2012) 0.75

Modified Widman flap and non-surgical therapy using chlorhexidine chip in the treatment of moderate to deep periodontal pockets: A comparative study. J Indian Soc Periodontol (2010) 0.75

Comparison of Periochip (chlorhexidine gluconate 2.5 mg) and Arestin (Minocycline hydrochloride 1 mg) in the management of chronic periodontitis. Indian J Dent (2015) 0.75

Comparative evaluation of subgingivally delivered xanthan-based chlorhexidine gel and herbal extract gel in the treatment of chronic periodontitis. J Indian Soc Periodontol (2014) 0.75

Adjunctive Effects of A Piscean Collagen-Based Controlled-Release Chlorhexidine Chip in the Treatment of Chronic Periodontitis: A Clinical and Microbiological Study. J Clin Diagn Res (2015) 0.75

Articles by these authors

(truncated to the top 100)

Periodontal disease and cardiovascular disease. J Periodontol (1996) 5.78

Bacteriology of experimental gingivitis in young adult humans. Infect Immun (1982) 4.14

Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study. Lancet (1999) 4.07

Comparative bacteriology of juvenile periodontitis. Infect Immun (1985) 3.09

Periodontal disease and adverse pregnancy outcomes: a systematic review. BJOG (2006) 2.98

Advances in the pathogenesis of periodontitis: summary of developments, clinical implications and future directions. Periodontol 2000 (1997) 2.62

Nonspecific adherence by Actinobacillus actinomycetemcomitans requires genes widespread in bacteria and archaea. J Bacteriol (2000) 2.46

Acute-phase inflammatory response to periodontal disease in the US population. J Dent Res (2000) 2.38

The Brompton mixture versus morphine solution given orally: effects on pain. Can Med Assoc J (1979) 2.23

Relationship of periodontal disease to carotid artery intima-media wall thickness: the atherosclerosis risk in communities (ARIC) study. Arterioscler Thromb Vasc Biol (2001) 2.20

flp-1, the first representative of a new pilin gene subfamily, is required for non-specific adherence of Actinobacillus actinomycetemcomitans. Mol Microbiol (2001) 2.09

Intraexaminer and interexaminer reliability in the diagnosis of oral epithelial dysplasia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (1995) 2.09

Interaction of wheat germ agglutinin with sialic acid. Biochemistry (1979) 1.87

Nasopalatine duct cyst: an analysis of 334 cases. J Oral Maxillofac Surg (1991) 1.82

Periodontitis: a risk factor for coronary heart disease? Ann Periodontol (1998) 1.77

The use of crevicular fluid prostaglandin E2 levels as a predictor of periodontal attachment loss. J Periodontal Res (1986) 1.72

Clinical outcomes for early childhood caries: influence of aggressive dental surgery. J Dent Child (Chic) (2004) 1.71

Genes for tight adherence of Actinobacillus actinomycetemcomitans: from plaque to plague to pond scum. Trends Microbiol (2001) 1.68

Effect of after-meal sucrose-free gum-chewing on clinical caries. J Dent Res (2001) 1.67

Direct selection of IS903 transposon insertions by use of a broad-host-range vector: isolation of catalase-deficient mutants of Actinobacillus actinomycetemcomitans. J Bacteriol (1999) 1.66

Treatment with subantimicrobial dose doxycycline improves the efficacy of scaling and root planing in patients with adult periodontitis. J Periodontol (2000) 1.65

Age-related decreases in insulin-like growth factor-I and transforming growth factor-beta in femoral cortical bone from both men and women: implications for bone loss with aging. J Clin Endocrinol Metab (1994) 1.63

Temperature differences at periodontal sites in health and disease. J Periodontol (1992) 1.63

Evidence of a substantial genetic basis for risk of adult periodontitis. J Periodontol (2000) 1.62

Prevalence of white spot lesions during orthodontic treatment with fixed appliances. Angle Orthod (2011) 1.57

Metabolic regulation of the arginyl and valyl transfer ribonucleic acid synthetases in bacteria. J Biol Chem (1974) 1.55

Nonspecific adherence and fibril biogenesis by Actinobacillus actinomycetemcomitans: TadA protein is an ATPase. J Bacteriol (2001) 1.53

Bacteriology of experimental gingivitis in children. Infect Immun (1984) 1.50

Maternal periodontitis and prematurity. Part II: Maternal infection and fetal exposure. Ann Periodontol (2001) 1.48

Relationship of serum antibody to attachment level patterns in young adults with juvenile periodontitis or generalized severe periodontitis. J Periodontol (1987) 1.47

A phase I/II clinical trial to evaluate a combination of recombinant human platelet-derived growth factor-BB and recombinant human insulin-like growth factor-I in patients with periodontal disease. J Periodontol (1997) 1.44

Synthesis of the first component of human complement in vitro. J Exp Med (1968) 1.44

Generalized osteoarthritis associated with increased insulin-like growth factor types I and II and transforming growth factor beta in cortical bone from the iliac crest. Possible mechanism of increased bone density and protection against osteoporosis. Arthritis Rheum (1993) 1.42

The association between periodontal diseases and cardiovascular diseases: a state-of-the-science review. Ann Periodontol (2001) 1.42

Structural and genetic analyses of O polysaccharide from Actinobacillus actinomycetemcomitans serotype f. Infect Immun (2001) 1.41

Gingival crevicular blood for assessment of blood glucose in diabetic patients. J Periodontol (1993) 1.39

Identification of Actinobacillus actinomycetemcomitans: polymerase chain reaction amplification of lktA-specific sequences. Oral Microbiol Immunol (1993) 1.38

Treatment of periodontitis by local administration of minocycline microspheres: a controlled trial. J Periodontol (2001) 1.35

Periodontal medicine: the emergence of a new branch of periodontology. Periodontol 2000 (2000) 1.35

Macrophage cell lines produce osteoinductive signals that include bone morphogenetic protein-2. Bone (2002) 1.34

Sustained local delivery of chlorhexidine in the treatment of periodontitis: a multi-center study. J Periodontol (1997) 1.33

Quantitation and immunocytochemical localization of human skin collagenase in basal cell carcinoma. J Invest Dermatol (1977) 1.33

Relationship of periodontal disease and edentulism to stroke/TIA. J Dent Res (2003) 1.32

Comparison of canine and non-human primate animal models for periodontal regenerative therapy: results following a single administration of PDGF/IGF-I. J Periodontol (1994) 1.32

Comparative effects of platelet-derived growth factor-BB and insulin-like growth factor-I, individually and in combination, on periodontal regeneration in Macaca fascicularis. J Periodontal Res (1996) 1.31

Effects of a Porphyromonas gingivalis infection on inflammatory mediator response and pregnancy outcome in hamsters. Infect Immun (1994) 1.30

Antibiotic susceptibilities of periodontal bacteria. In vitro susceptibilities to eight antimicrobial agents. J Periodontol (1985) 1.30

Odontogenic keratocysts: a clinical and histologic comparison of the parakeratin and orthokeratin variants. J Oral Maxillofac Surg (1992) 1.29

Serum antibody reactive with predominant organisms in the subgingival flora of young adults with generalized severe periodontitis. Infect Immun (1985) 1.28

Inflammatory mediator response as a potential risk marker for periodontal diseases in insulin-dependent diabetes mellitus patients. J Periodontol (1997) 1.28

Immunological studies of young adults with severe periodontitis. I. Medical evaluation and humoral factors. J Periodontal Res (1981) 1.26

Polyclonal B-cell activation induced by extracts of Gram-negative bacteria isolated from periodontally diseased sites. Infect Immun (1981) 1.25

Immunological studies of young adults with severe periodontitis. II. Cellular factors. J Periodontal Res (1981) 1.25

Caries risk assessment by a cross-sectional discrimination model. J Dent Res (1993) 1.25

Bacterial infection promotes DNA hypermethylation. J Dent Res (2007) 1.22

Effects of smokeless tobacco on the periodontal, mucosal and caries status of adolescent males. J Oral Pathol (1985) 1.21

Evidence for autosomal dominant inheritance and race-specific heterogeneity in early-onset periodontitis. J Periodontol (1994) 1.21

Secretion of RTX leukotoxin by Actinobacillus actinomycetemcomitans. Infect Immun (2000) 1.20

Gingival crevicular fluid interleukin-1beta, prostaglandin E2 and periodontal status in a community population. J Clin Periodontol (2007) 1.20

Dental infections and atherosclerosis. Am Heart J (1999) 1.20

Sequential model to describe the nicotinic synaptic current. Biophys J (1989) 1.19

Synthesis of the first component of guinea pig complement by columnar epithelial cells of the small intestine. J Immunol (1968) 1.19

Neutrophil chemotaxis in families with localized juvenile periodontitis. J Periodontal Res (1985) 1.18

Monocytic TNF alpha secretion patterns in IDDM patients with periodontal diseases. J Clin Periodontol (1997) 1.17

Comparison of debris extruded apically in straight canals: conventional filing versus profile .04 Taper series 29. J Endod (1998) 1.16

Factor VIII and other hemostasis variables are related to incident diabetes in adults. The Atherosclerosis Risk in Communities (ARIC) Study. Diabetes Care (1999) 1.16

Caries risk assessment in a longitudinal discrimination study. J Dent Res (1993) 1.15

The effect of systemically administered PDGF-BB on the rodent skeleton. J Bone Miner Res (1996) 1.15

Developmental expression of 44-kDa bone phosphoprotein (osteopontin) and bone gamma-carboxyglutamic acid (Gla)-containing protein (osteocalcin) in calcifying tissues of rat. Differentiation (1988) 1.14

Changes in crevicular fluid levels of interleukin-1 beta, leukotriene B4, prostaglandin E2, thromboxane B2 and tumour necrosis factor alpha in experimental gingivitis in humans. J Periodontal Res (1993) 1.14

The secretion of PGE2, IL-1 beta, IL-6, and TNF alpha by adherent mononuclear cells from early onset periodontitis patients. J Periodontol (1994) 1.13

Epigenetics: connecting environment and genotype to phenotype and disease. J Dent Res (2009) 1.13

Frictional resistance of ceramic and stainless steel orthodontic brackets. Am J Orthod Dentofacial Orthop (1990) 1.13

Variation in periodontal floras. Infect Immun (1984) 1.12

Growth factors to stimulate bone formation. J Bone Miner Res (1993) 1.11

Effects of ketogenic diet on development and behavior: preliminary report of a prospective study. Dev Med Child Neurol (2001) 1.11

Oral disease, cardiovascular disease and systemic inflammation. Periodontol 2000 (2000) 1.10

Genome-wide association study of periodontal pathogen colonization. J Dent Res (2012) 1.10

Serum immunoglobulin G subclass concentrations in periodontally healthy and diseased individuals. Infect Immun (1994) 1.10

Influence of smoking and race on immunoglobulin G subclass concentrations in early-onset periodontitis patients. Infect Immun (1996) 1.10

Measurement of prostaglandin E in crevicular fluid. J Clin Periodontol (1981) 1.09

Properties of an inducible extracellular neuraminidase from an Arthrobacter isolate. J Bacteriol (1977) 1.09

Effects of race and periodontal status on antibody reactive with Actinobacillus actinomycetemcomitans strain Y4. J Periodontal Res (1988) 1.09

Collagenase in human cornea: immunologic localization. Arch Ophthalmol (1980) 1.09

N-nitroso-compound impurities in herbicide formulations. J Agric Food Chem (1977) 1.08

A 5-year study of attachment loss in community-dwelling older adults: incidence density. J Periodontal Res (1997) 1.08

Genetic analysis of the requirement for flp-2, tadV, and rcpB in Actinobacillus actinomycetemcomitans biofilm formation. J Bacteriol (2006) 1.07

Antibody reactive with Porphyromonas gingivalis serotypes K1-6 in adult and generalized early-onset periodontitis. J Periodontol (1999) 1.07

Periodontal disease treatment by local drug delivery. J Periodontol (1985) 1.07

Utilisation of locally delivered doxycycline in non-surgical treatment of chronic periodontitis. A comparative multi-centre trial of 2 treatment approaches. J Clin Periodontol (2001) 1.07

Reflector design for illumination with extended sources: the basic solutions. Appl Opt (1994) 1.07

Exploratory case-control analysis of psychosocial factors and adult periodontitis. J Periodontol (1996) 1.07

Inflammatory mediators of the terminal dentition in adult and early onset periodontitis. J Periodontal Res (1998) 1.06

Localized juvenile periodontitis and generalized severe periodontitis: clinical findings. J Clin Periodontol (1984) 1.06

The association between Porphyromonas gingivalis-specific maternal serum IgG and low birth weight. J Periodontol (2001) 1.06

Antiphosphorylcholine antibody levels are elevated in humans with periodontal diseases. Infect Immun (1999) 1.06

Role of lysyl epsilon-amino groups in adenosine diphosphate binding and catalytic activity of pyruvate kinase. J Biol Chem (1971) 1.05

Evaluation of periodontal treatments using controlled-release tetracycline fibers: clinical response. J Periodontol (1995) 1.05

Conjugal transfer of broad-host-range incompatibility group P and Q plasmids from Escherichia coli to Actinobacillus actinomycetemcomitans. Infect Immun (1993) 1.05

Influence of risk factors on the pathogenesis of periodontitis. Periodontol 2000 (1997) 1.05